<?xml version="1.0" encoding="UTF-8"?>
<ref id="B6-biomolecules-10-00817">
 <label>6.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reis</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Matos</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Duarte</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Ahmed</surname>
    <given-names>O.B.</given-names>
   </name>
   <name>
    <surname>Ferreira</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Lage</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ferreira</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Epoxylathyrane Derivatives as MDR Selective Compounds for Disabling Multidrug Resistance in Cancer</article-title>
  <source>Front. Pharmacol.</source>
  <year>2020</year>
  <volume>11</volume>
  <fpage>599</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2020.00599</pub-id>
  <pub-id pub-id-type="pmid">32457612</pub-id>
 </element-citation>
</ref>
